Puberty Blockers: A Blight on the Brain

Centred on the University of Lille, France, in September 2022, a group of international researchers reported in the prestigious journal Science that the progressive devolution in mental abilities of people suffering from Down Syndrome (DS) could be attributed to an associated reduction in the production of a particular hormone. They based their assertion on the results of experiments they had performed on genetically engineered mouse models of DS and on a small group of adult human sufferers of DS, in all of which the levels of the hormone had been restored to normal by various experimental means.[1] The researchers report “rescue” of cognition by replacement of that hormone and suggest the process may have a positive role in the treatment of other neuro-degenerative diseases such as Parkinson’s disease, and even ageing.

The Lille researchers are not isolated in their findings. Researchers in Iran have also found protective effects of that hormone against the development…